Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Influenza-virus-vaccine

Various toxicities: 2 case reports

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Panatto D, et al. Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59-adjuvanted influenza vaccine in older adults: Results from three consecutive seasons. Influenza and other Respiratory Viruses 14: 61-66, No. 1, Jan 2020. Available from: URL: http://doi.org/10.1111/irv.12685

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Influenza-virus-vaccine. Reactions Weekly 1791, 144 (2020). https://doi.org/10.1007/s40278-020-74989-0

    Download citation